⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL20293396 | 0.96 | — | — | |
| SCHEMBL319529 | 0.91 | — | — | |
| SCHEMBL352244 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL2948039 | 0.86 | — | — | |
| SCHEMBL1830968 | 0.84 | TSHR (0.41) | — | |
| SCHEMBL1833697 | 0.84 | TSHR (0.41) | — | |
| SCHEMBL208999 | 0.84 | — | — | |
| SCHEMBL29002295 | 0.84 | TSHR (0.41) | — | |
| Hydrochloric Acid SCHEMBL1459865 | 0.84 | — | — | |
| SCHEMBL9801578 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117957210-A | Composition of matter from unsaturated nitriles | 英威达纺织（英国）有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2023122842-A1 | METHOD FOR PREPARING APALUTAMIDE, SYNTHESIS INTERMEDIARIES, AND AMORPHOUS SOLID DISPERSION CONTAINING APALUTAMIDE | GADOR LIMITADA (CL) | 2023-07-06 | — | — | WO | claimed |
| EP-1546150-B1 | PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES | AMURA THERAPEUTICS LTD (GB) | 2009-03-04 | — | — | EP | claimed |
| US-20260053932-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS INC (US) | 2026-02-26 | — | — | US | disclosed |
| US-12419960-B2 | Compounds and methods for the targeted degradation of androgen receptor and associated methods of use | ARVINAS OPERATIONS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| CN-120441457-A | Preparation method of (1R, 2R) -amino-cyclobutanol | 浙江工业大学 | 2025-08-08 | — | — | CN | disclosed |
| CN-120441457-A | Preparation method of (1R, 2R) -amino-cyclobutanol | 浙江工业大学 | 2025-08-08 | — | — | CN | disclosed |
| EP-4538268-A1 | PYRIDAZIN-3-CARBOXAMIDE COMPOUND AS TYK2 INHIBITOR | Guangzhou Fermion Technology Co., Ltd. (CN) | 2025-04-16 | — | — | EP | disclosed |
| US-20240270740-A1 | INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF | VENTUS THERAPEUTICS U.S., INC. | 2024-08-15 | — | — | US | disclosed |
| CN-117957210-A | Composition of matter from unsaturated nitriles | 英威达纺织（英国）有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117929324-A | Rapid streptomycin detection method | 集美大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-104507933-A | Aminoquinazoline and pyridopyrimidine derivatives | HOFFMANN LA ROCHE | 2015-04-08 | — | — | CN | disclosed |
| US-8754101-B2 | N-cyclobutyl-imidazopyridine-methylamine as TRPV1 antagonists | GLAXO GROUP LIMITED (GB) | 2014-06-17 | — | — | US | disclosed |
| US-20140051720-A1 | N-Cyclobutyl - Imidazopyridine - Methylamine As TRPV1 Antagonists | GLAXO GROUP LIMITED (GB) | 2014-02-20 | — | — | US | disclosed |
| EP-2697221-A1 | N- CYCLOBUTYL - IMIDAZOPYRIDINE - METHYLAMINE AS TRPV1 ANTAGONISTS | Glaxo Group Limited (GB) | 2014-02-19 | — | — | EP | disclosed |
| WO-2012139963-A1 | N- CYCLOBUTYL - IMIDAZOPYRIDINE - METHYLAMINE AS TRPV1 ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2012-10-18 | — | — | WO | disclosed |
| CN-101035795-B | Thiazolyl dihydroindazoles | BOEHRINGER INGELHEIM INT | 2012-03-21 | — | — | CN | disclosed |
| CN-101035795-A | Thiazolyl dihydroindazoles | BOEHRINGER INGELHEIM INT (DE) | 2007-09-12 | — | — | CN | disclosed |
| CN-1324008-C | Novel compounds and compositions as cathepsin inhibitors | AVENTIS PHARMA INC (US) | 2007-07-04 | — | — | CN | disclosed |
| CN-1553892-A | Novel compounds and compositions as cathepsin inhibitors | ����˹��ҩ�﹫˾ | 2004-12-08 | — | — | CN | disclosed |